This new 260-page report from Venture Planning Group provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines,, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Opportunities in the French Drugs of Abuse Testing Market? is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 260 pages and 10 tables
SIMILAR MARKET STUDIES
2016-2020 World Factor Assays Testing Market: Ambulatory Centers, Commercial Labs, Hospitals, Physician Offices, POC/Point-of-Care Locations--Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Factor Assays testing specifically, will become more ...
March 2016 | $0 | View Details >>
Notes: Sales, means the sales volume of Prenatal Screening Test Revenue, means the sales value of Prenatal Screening Test This report studies sales (consumption) of Prenatal Screening Test in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Angle Plc ...
October 2016 | $3800 | View Details >>
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report provides test volume and sales forecasts; compares features of major ...
March 2017 | $0 | View Details >>
Complete report $2,250. DataPack (test volumes, sales forecasts, supplier shares) $1,450.RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the ...
November 2015 | $1450 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research